Plavix Hearing Scheduled For Aug. 18 After Sanofi/Bristol File Preliminary Injunction

Apotex launch of generic clopidogrel is the “largest ‘at-risk’ infringing launch of all time,” Sanofi/Bristol court filing claims.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet